seda
no_dataFlash
12:46
If regulatory approval is obtained, production of the gene therapy UX111 by Ultragenyx Pharmaceutical Inc (RARE) will take place in the United States, with plans to proceed simultaneously at both Andelyn Biosciences and Ultragenyx's own facilities.This dual-track strategy aims to strengthen supply chain resilience and provide production capacity assurance for future commercialization efforts.
12:46
DexCom announced that it will officially release its financial results for the first quarter of 2026 on April 30, 2026, at 4:30 p.m. Eastern Time.At that time, the company will also hold an investor conference call to provide a detailed interpretation of its quarterly performance and answer related questions.
12:43
US February trade deficit reached $57.35 billionGlonghui, April 2｜The US trade deficit in February was $57.35 billion, while the market expectation was a deficit of $62 billion. US exports in February were $314.79 billion, a year-on-year increase of 4.2%; imports were $372.14 billion, an increase of 4.3%.